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Abstract
Introduction A candidate gene approach, in a large case–control association study in the Dutch
population, has shown that a 480 kb block on chromosome 4q27 encompassing KIAA1109/Tenr/IL2/
IL21  genes is associated with rheumatoid arthritis. Compared with case–control association
studies, family-based studies have the added advantage of controlling potential differences in
population structure. Therefore, our aim was to test this association in populations of European
origin by using a family-based approach.
Methods A total of 1,302 West European white individuals from 434 trio families were genotyped
for the rs4505848, rs11732095, rs6822844, rs4492018 and rs1398553 polymorphisms using the
TaqMan Allelic discrimination assay (Applied Biosystems). The genetic association analyses for each
SNP and haplotype were performed using the Transmission Disequilibrium Test and the genotype
relative risk.
CI: confidence interval; IL: interleukin; OR: odds ratio; RA: rheumatoid arthritis; SNP: single nucleotide polymorphism.Arthritis Research & Therapy 2009, 11:R45 http://arthritis-research.com/content/11/2/R45
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Results We observed evidence for association of the heterozygous rs4505848-AG genotype with
rheumatoid arthritis (P = 0.04); however, no significance was found after Bonferroni correction. In
concordance with previous findings in the Dutch population, we observed a trend of
undertransmission for the rs6822844-T allele and rs6822844-GT genotype to rheumatoid arthritis
patients. We further investigated the five SNP haplotypes of the KIAA1109/Tenr/IL2/IL21 gene
region. We observed, as described in the Dutch population, a nonsignificant undertransmission of
the AATGG haplotype to rheumatoid arthritis patients.
Conclusions Using a family-based study, we have provided a trend for the association of the
KIAA1109/Tenr/IL2/IL21 gene region with rheumatoid arthritis in populations of European descent.
Nevertheless, we failed to replicate a significant association of this region in our rheumatoid
arthritis family sample. Further investigation of this region, including detection and testing of all
variants, is required to confirm rheumatoid arthritis association.
Introduction
Rheumatoid arthritis (RA) is a common autoimmune
inflammatory disease of unknown cause, in which both
genetic and environmental risk factors have been impli-
cated [1]. Since the genetic contribution to RA has been
estimated to be between 50% and 60%, identification of
genes contributing to disease is important for the under-
standing of underlying biological mechanisms [2].
In addition to human leucocyte antigen (HLA) [3] – the
first identified genetic risk factor – and four other repli-
cated regions – including the protein tyrosine phos-
phatase N22 gene (PTPN22) [4], the TNF receptor-
associated factor 1 gene (TRAF1)/complement compo-
nent factor 5 (C5) locus [5-7], the 6q23 locus near the
TNFα-induced protein 3 gene (TNFAIP3) [8,9], and the
signal transducer and activator of transcription 4 (STAT4)
gene [10,11] – a new genetic region associated with RA
was described in the Dutch population [12]. This region
encompassing KIAA1109/Tenr/IL2/IL21 is contained in a
large block (480 kb) of linkage disequilibrium located on
chromosome 4q27 and includes the IL2 and IL21 genes,
which are both plausible functional candidate loci for RA.
Five SNPs (rs4505848, rs11732095, rs6822844,
rs4492018 and rs1398553) of the block were investigated
in a sample set consisting of 1,047 RA patients and 929
controls, showing a significant association of the
rs6822844-T allele and the rs6822844-GT genotype (P =
0.0002, odds ratio (OR) = 0.72, 95% confidence interval
(CI) = 0.61 to 0.86; and P = 0.0009, OR = 0.71, 95% CI =
0.58 to 0.87, respectively) and of a specific haplotype
(AATGG) (P = 0.00025, OR = 0.70, 95% CI = 0.57 to 0.85)
with RA [12].
Furthermore, in the North American Rheumatoid Arthri-
tis Consortium and in the Epidemiological Investigation
of Rheumatoid Arthritis populations, rs6822844 and
rs1398553 SNPs were significantly associated with RA (P
= 0.01, OR = 0.84, 95% CI = 0.74 to 0.96; and P = 0.003,
OR = 1.17, 95% CI = 1.05 to 1.30, respectively) [6]. In
addition, the last meta-analysis performed with the North
American Rheumatoid Arthritis Consortium, the Epide-
miological Investigation of Rheumatoid Arthritis and the
Wellcome Trust Case Control Consortium studies, with
3,393 RA patients and 12,462 controls, observed evidence
of association of 4q27 with RA in an independent replica-
tion, suggesting that 4q27 is a true-positive association
[13].
Given that association studies compare the frequencies in
patients versus healthy individuals, unknown biases in
control frequencies may lead to spurious associations.
Family-based association studies therefore remain impor-
tant to definitively establish association, especially when
small effect sizes as well as variability in allele frequency
in different populations are observed. With the aim to fur-
ther substantiate the association at the KIAA1109/Tenr/
IL2/IL21 gene region, we therefore took advantage of one
of the largest reported European family resources dedi-
cated to RA family-based studies.
Materials and methods
Study design and study population
DNA was available from 434 white trio families from
Western Europe through the European Consortium on
Rheumatoid Arthritis Families collection followed by the
selection of individuals fulfilling the American College of
Rheumatology 1987 criteria for RA [14], according to the
rheumatologist in charge of the patient. Each family con-
sisted of one RA patient and both parents, with the ethnic-
ity as determined by grandparental origin.
Characteristics of the 434 RA European Caucasian fami-
lies are reported in Table 1. The 434 families included 308
families from France, 51 families from Italy, 32 families
from Spain, 20 families from Belgium, nine families from
the Netherlands and 14 families from Portugal. Families
with an additional affected sibling and with RA patientsArthritis Research & Therapy 2009, 11:R45 http://arthritis-research.com/content/11/2/R45
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aged <18 years were excluded. All individuals provided
written informed consent and the study was approved by
the Ethics Committee of Hôpital Kremlin-Bicêtre (Paris,
France).
Genotyping
All samples were genotyped using the TaqMan allelic dis-
crimination assay according to the manufacturer's instruc-
tions (Applied Biosystems, Foster City, CA, USA). Centre
d'Etude du Polymorphisme Humain DNA samples were
co-genotyped with all our samples, with no inconsisten-
cies detected. The genotyping success rate in the 434 trio
families was 100% (parents and probands included).
Statistical analysis
Using the previously reported frequencies for the
rs6822844-T allele in Dutch RA patients (14.1%) and in
controls (18.5%) [12], the power to detect an association
was calculated using the method described by Garnier and
colleagues [15]. The Hardy–Weinberg equilibrium was
checked in the control group (constituting the nontrans-
mitted parental chromosomes from the trio) prior to anal-
ysis. The association analysis relied on the Transmission
Disequilibrium Test, which for a given allele compares its
transmission from heterozygous parents to RA patients
with the transmission expected from Mendel's law (that
is, 50%) [16].
Secondly, we used the genotype relative risk, which com-
pares the affected offspring's genotype with the control
genotype derived from nontransmitted parental chromo-
somes [17]. ORs were calculated and 95% CIs were
approximated using Woolf's method [18], with Haldane's
correction [19]. Haplotypes were generated using GENE-
HUNTER software [20]. We then carried out multi-locus
tests of association testing haplotypes of SNPs using the
Transmission Disequilibrium Test and haplotype relative
risk. P values were adjusted with Bonferroni correction
[21] for each independent test performed.
Results
Power calculation
Using the previously reported frequencies for the
rs6822844-T allele in Dutch RA patients (14.1%) and in
controls (18.5%) [12], association analysis of 434 trio
families provides an 80% power to reach statistical signif-
icance (P <0.05).
Hardy–Weinberg equilibrium check
The five SNPs in the sample investigated were in Hardy–
Weinberg equilibrium in the control group.
Test for association in RA trio families
A total of 1,302 European individuals from 434 trio fam-
ilies (one RA case and both parents) were analyzed. Three
hundred and eight families were of French origin and 126
were from other continental Western European countries.
With the rs6822844 (G/T) SNP we observed deviation
from Mendel's first law, with a nonsignificant undertrans-
mission of 45.3% of the T allele to the patients in the 434
families (P = 0.24) (Table 2). No significant association
with RA was detected for the four other SNPs (Table 2).
Since RA is a heterogeneous disease and distinct subsets of
patients are characterized by the presence of autoantibod-
ies such a rheumatoid factor and anti-citrullinated protein
antibodies, we also performed a stratified analysis for the
presence or absence of rheumatoid factor or anti-citrulli-
nated protein antibodies; no associations were detected
(data not shown). Furthermore, the same tests were per-
formed in subgroups stratified for the presence of the
HLA-DRB1 shared epitope, PTPN22-1858T and TRAF1/C5
rs10818488-A variant, and no associations were detected
(data not shown). One of the advantages of family trio
data is that they provide perfectly matched controls for
each patient investigated. Each patient chromosome,
transmitted by a given parent, is perfectly matched for the
population of origin with the untransmitted chromosome
of each heterozygous parent. The genotype relative risk
Table 1
Characteristics of rheumatoid arthritis (RA) index cases
Characteristic RA families (n = 434)
Females (n (%)) 375 (86%)
Mean age at disease onset (years) (± standard deviation) 31.1 (9.7)
Mean disease duration (years) (± standard deviation) 9.8(8.5)
With bone erosions (n (%)) 336 (77%)
Seropositive for rheumatoid factor (n (%)) 323 (76%) (out of 425 RA patients)
Seropositive for anti-cycle citrullinated peptides antibodies (n (%)) 214 (76%) (out of 282 RA patients)
Carrying at least one HLA-DRB1 shared epitope allele (n (%))a 152 (77%) (out of 197 RA patients)
Carrying at least one PTPN22-1858T allele (n (%)) 115 (27%)
Carrying the TRAF1/C5 rs10818488-A variant (n (%)) 277 (64%)
aDRB1*0101, DRB1*0102, DRB1*0401, DRB1*0404, DRB1*0405, DRB1*0408, DRB1*1001.Arthritis Research & Therapy 2009, 11:R45 http://arthritis-research.com/content/11/2/R45
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analysis of the rs4505848 (A/G) SNP showed an associa-
tion of the heterozygous AG genotype with RA (P = 0.04,
OR = 1.32, 95% CI = 1.01 to 1.72) (Table 3). The signifi-
cance threshold was not reached, however, after Bonfer-
roni correction. In the four other SNPs, no association
with RA was detected (Table 3). In concordance with pre-
vious findings in the Dutch population, we observed an
undertransmission of the rs6822844-T allele and the
rs6822844-GT genotype, but without significance (Tables
2 and 3).
We further investigated the five SNP (rs4505848,
rs11732095, rs6822844, rs4492018 and rs1398553) hap-
lotypes of the KIAA1109/Tenr/IL2/IL21 gene region. These
seven haplotypes of the combined five SNPs of the block
have a pooled frequency of 96%. We observed a nonsig-
nificant undertransmission of the AATGG haplotype (P =
0.19) (Table 4), which was reported as associated with RA
in the Dutch study [12]. No relative risk was detected for
any haplotype genotype (data not shown). There were no
differences between families of French origin and other
continental Western Europe families, as well as no differ-
ences between paternal transmission and maternal trans-
mission for all statistical analyses performed (data not
shown).
Discussion
A recent case–control study in the Dutch population has
shown association of RA, celiac disease and type 1 diabe-
tes with the 4q27 gene region. In that study the
rs6822844-T allele was reported to be a perfect proxy for
a haplotype that is highly associated with autoimmune
diseases with frequencies of 0.13 in cases versus 0.19 in
North European controls [12].
In addition, a study from the Wellcome Trust Case Con-
trol Consortium identified this 4q27 region in a search for
risk factors for type 1 diabetes [22]. In a follow-up study,
some support for this association with type 1 diabetes was
provided [23]. The last meta-analysis of data from three
genome-wide association studies of type 1 diabetes – test-
ing 305,090 SNPs in 3,561 type 1 diabetes cases and 4,646
controls of European ancestry – obtained further support
for 4q27 type 1 diabetes association (P = 1.9 × 10-8), indi-
cating that this is a true type 1 diabetes locus [24]. The
same region was studied in inflammatory bowel diseases
such as Crohn's disease and ulcerative colitis. Four SNPs
Table 2
Family-based association of the chromosome 4q27 gene region with rheumatoid arthritis: Transmission Disequilibrium Test
4q27 region SNP Allele Transmitted allele Untransmitted allele Transmissiona (%) P value
rs4505848 A 185 189 49.5 0.84
rs11732095 A 96 78 55.2 0.17
rs6822844 T 97 114 45.3 0.24
rs4492018 G 183 174 51.3 0.63
rs1398553 G 182 182 50 1
aPercentage of transmission from heterozygous parents.
Table 3
Family-based association of the chromosome 4q27 gene region with rheumatoid arthritis: genotype relative risk
SNP Genotype RA cases (n) Controls (n) Odds ratio (95% confidence interval) P value
rs4505848 GG 38 51 0.72 (0.46 to 1.12) 0.18 (GG vs. AA + AG)
AG 213 183 1.32 (1.01 to 1.72) 0.04 (AG vs. GG + AA)a
AA 182 199 0.85 (0.65 to 1.11) 0.28 (AA vs. AG + GG)
rs11732095 GG 7 9 0.77 (0.28 to 2.09) 0.8 (GG vs. AA + AG)
AG 87 101 0.83 (0.6 to 1.15) 0.28 (AG vs. GG + AA)
AA 340 324 1.23 (0.9 to 1.68) 0.23 (AA vs. AG + GG)
rs6822844 TT 8 11 0.72 (0.29 to 1.81) 0.64 (TT vs. GG + TG)
TG 99 110 0.87 (0.64 to 1.19) 0.43 (TG vs. TT + GG)
GG 327 313 1.18 (0.87 to 1.6) 0.32 (GG vs. TT + TG)
rs4492018 GG 235 232 1.03 (0.79 to 1.35) 0.89 (GG vs. AA + AG)
AG 174 171 1.03 (0.78 to 1.35) 0.89 (AG vs. GG + AA)
AA 25 31 0.79 (0.46 to 1.36) 0.49 (AA vs. AG + GG)
rs1398553 GG 204 214 0.91 (0.7 to 1.19) 0.54 (GG vs. AA + AG)
AG 195 175 1.2 (0.92 to 1.57) 0.20 (AG vs. GG + AA)
AA 35 45 0.77 (0.49 to 1.21) 0.30 (AA vs. AG + GG)
aP value was not significant after Bonferroni correction.Arthritis Research & Therapy 2009, 11:R45 http://arthritis-research.com/content/11/2/R45
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were genotyped in three cohorts concerning 4,782 cases
(3,194 ulcerative colitis, 1,588 Crohn's disease) and 2,616
controls. All four SNPs were strongly associated with
ulcerative colitis and moderately associated with Crohn's
disease [25]. The 4q27 locus was also reported to be asso-
ciated with celiac disease [26]. Recent evidence is also pro-
vided of a role for this region in psoriasis and psoriatic
arthritis [27]. Finally, a genetic association with systemic
lupus erythematosus and two SNPs located within the IL-
21 gene was found in a case–control study (1,318 cases
and 1,318 controls) [28]. All of these studies provide evi-
dence that 4q27 seems to be a common locus for multiple
forms of autoimmune diseases.
In our family-based study, compared with the Dutch
study, we have detected a similar undertransmission of
the rs6822844-T allele, the rs6822844-GT genotype and
the AATGG haplotype, but without significance. Further-
more, we observed evidence of association between RA
and the rs4505848-AG genotype, but no significance was
found after Bonferroni correction. These results exclude
the 4q27 locus from being a major RA genetic region, but
a minor association should be not excluded and needs to
be tested in a larger RA trio sample. Furthermore the
already cited last RA meta-analysis, suggesting a 4q27
true-positive association, was performed in a large
number of individuals. For the rs4572894 SNP tested,
there was only a 2% variation between RA and non-RA
minor allele frequency (27% versus 29%, respectively)
with a P value of 1.1% [13]. The putative effect of the 4q27
locus in RA is therefore very small and difficult to replicate
in our RA family sample. In addition, a two-stage genome-
wide association study of RA in the Spanish population
did not found 4q27 as a RA susceptibility gene region
[29].
The long region of linkage disequilibrium at chromosome
4q27 contains several genes: testis nuclear RNA-binding
protein, a gene encoding a protein of unknown function
(KIAA1109), and genes encoding the IL-2 and IL-21
cytokines. Testis nuclear RNA-binding protein is
expressed primarily in the testis and KIAA1109 transcripts
are ubiquitous, hence their roles in autoimmunity are not
particularly compelling. Both IL-2 and IL-21 belong to the
type 1 cytokine family, share a large degree of homology,
and possess pleotropic functions in immune cells [26].
These two genes are both plausible functional candidates
as genetic modifiers of autoimmunity, and thus have par-
ticular interest to RA.
IL-2 exerts its effects on many cell types, the most promi-
nent of which is the T lymphocyte. Accordingly, a major
function of IL-2 is to promote proliferation and expansion
of both antigen-specific clones of CD4+ and CD8+ T cells
as well as to induce production of other cytokines. In
CD4+ T cells, IL-2 plays a nonredundant role in the devel-
opment of CD4+ CD25+ regulatory T cells. Accumulating
evidence supports CD4+ CD25high regulatory T cells play-
ing an essential role in controlling and preventing
autoimmunity [30]. In addition, the IL2 receptor (CD25)
susceptibility locus has recently been reported to be asso-
ciated with RA [22].
IL-21 is involved in both cell-mediated and humoral
responses and has a pleiotropic effect on a variety of
immune and nonimmune cells. In RA, the synovial fluid
and tissue have enhanced inflammatory responses to IL-
21 and elevated IL-21 receptor expression. In two animal
models – collagen-induced arthritis and adjuvant-
induced arthritis – treatment with an IL-21-blocking agent
ameliorated disease and/or reversed established disease,
and also lowered levels of IL-6 and IL-17 [31].
Conclusions
In the present study, using a family-based approach, we
have provided a trend for the association of the
KIAA1109/Tenr/IL2/IL21 gene region with RA in European
descent populations. Nevertheless, we failed to replicate a
significant association of this region in our RA family sam-
ple. Further investigation of this region, including detec-
tion and testing of all variants, is required to confirm RA
association.
Table 4
Family-based association for the seven haplotypesa: Transmission Disequilibrium Test
Haplotype Transmitted Untransmitted Transmissionb (%) P value
GAGGA 113 112 50 0.95
AAGAG 133 126 52 0.69
AATGG 76 93 45 0.19
AAGGG 110 102 52 0.58
AGGGG 67 67 50 1
GAGGG 81 64 56 0.16
AAGGA 53 43 55 0.31
ars4505848 (G/A) – rs11732095 (G/A) – rs6822844 (T/G) – rs4492018 (G/A) – rs1398553 (G/A). bPercentage of transmission from heterozygous 
parents.Arthritis Research & Therapy 2009, 11:R45 http://arthritis-research.com/content/11/2/R45
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